STAT3 Therapeutics develops drugs with broad applicability

Product Indication Stage
 

Open
Close
 
 
 
S3T-001

Head & Neck Squamous Cell Pre-Clinical
1 2 3 4 5 6

STAT3 Therapeutics is developing S3T-001 for Head and Neck Squamous Cell Carcinoma. The drug is currently in the pre-clinical stage.

Why?

Hyperactivated STAT3 plays an important regulatory role in 95% of all head and neck cancers.1 The STAT3 pathway has the potential to make a significant impact as a therapeutic target.

Open
Close
 
 
 
S3T-002

Non-Small Cell Lung Cancer Discovery
1 2 3 4 5 6

STAT3 Therapeutics is developing S3T-002 for Non-Small Cell Lung Cancer. The drug is currently in the discovery stage.

Why?

Accumulating evidence over the last two decades suggests a critical role for STAT3 as a point of convergence for various signaling pathways that are dysregulated in the disease.2

Open
Close
 
 
 
S3T-003

Glioblastoma Discovery
1 2 3 4 5 6

STAT3 Therapeutics is developing S3T-003 for Glioblastoma. The drug is currently in the discovery stage.

Why?

Persistent activation of STAT3 induces cell proliferation, anti-apoptosis, glioma stem cell maintenance, tumor invasion, angiogenesis, and immune evasion – making STAT3 an attractive therapeutic target and a prognostic indicator.3

Open
Close
 
 
 
S3T-004

Melanoma Discovery
1 2 3 4 5 6

STAT3 Therapeutics is developing S3T-004 for Melanoma. The drug is currently in the discovery stage.

Why?

Studies using keratinocyte-specific STAT3-deficient mice have revealed that STAT3 plays an important role in skin homeostasis including keratinocyte migration, wound healing, and hair follicle growth.4

Open
Close
 
 
References
  1. Darnell JE. (2005) Validating Stat3 in cancer therapy. Nat. Med. 11:595–6.
  2. Role of STAT3 in lung cancer; Pranabananda Dutta, Nafiseh Sabri, Jinghong Li, Willis X Li
    JAKSTAT. 2014; 3(4): e999503. Published online 2015 Jan 20. doi: 10.1080/21623996.2014.9996.2014.999503
    PMCID: PMC4580090
  3. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment; https://www.sciencedirect.com/science/article/pii/S0303720717300047?via%3Dihub
  4. Everardo Macias, Dharanija Rao, and John DiGiovanni, “Role of Stat3 in Skin Carcinogenesis: Insights Gained from Relevant Mouse Models,” Journal of Skin Cancer, vol. 2013, Article ID 684050, 10 pages, 2013. doi:10.1155/2013/684050